Hitzenbichler, Florian and Mohr, Arno and Camboni, Daniele and Simon, Michaela and Salzberger, Bernd and Hanses, Frank (2021) Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases. INFECTION, 49 (1). pp. 181-186. ISSN 0300-8126, 1439-0973
Full text not available from this repository. (Request a copy)Abstract
We present four cases with Gram-positive bacteremia (pathogens: MRSAn = 1, Enterococcusspp.n = 3) due to an intravascular source (left ventricular assist device:n = 2, transfemoral aortic valve implantationn = 1, prosthetic aortic valve:n = 1) where no curative treatment was available. These patients received indefinite, chronic suppressive (palliative) therapy with dalbavancin (500 mg weekly or 1000 mg biweekly regimens). Outcomes and clinical characteristics are described; treatment was effective in suppression of bacteremia in all patients over several months (range: 1 to more than 12 months), we observed no relevant side effects.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | SKIN; Dalbavancin; Bacteremia; Intravascular infection; Suppressive therapy; LVAD; Endocarditis |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Herz-, Thorax- und herznahe Gefäßchirurgie Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene Medicine > Institut für Epidemiologie und Präventivmedizin |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 18 May 2021 18:45 |
| Last Modified: | 18 May 2021 18:45 |
| URI: | https://pred.uni-regensburg.de/id/eprint/43767 |
Actions (login required)
 |
View Item |
